EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.3.1.122 | Asthma |
24455775 |
Administration of mycobacterial Ag85A and IL-17A fusion protein attenuates airway inflammation in a murine model of asthma. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
4
1
0 |
| 2.3.1.122 | Asthma |
29302700 |
Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma. |
ongoing research
therapeutic application
unassigned |
4
2
0 |
| 2.3.1.122 | Buruli Ulcer |
11500410 |
Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. |
therapeutic application
unassigned |
2
0 |
| 2.3.1.122 | Buruli Ulcer |
26393347 |
Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer. |
ongoing research
therapeutic application
unassigned |
2
3
0 |
| 2.3.1.122 | Buruli Ulcer |
30090691 |
IFN-? and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
2
1
2
0 |
| 2.3.1.122 | Carcinoma |
26238268 |
Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
4
4
0 |
| 2.3.1.122 | Carcinoma |
30542467 |
Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity. |
unassigned |
0 |
| 2.3.1.122 | Coinfection |
23369570 |
A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. |
ongoing research
therapeutic application
unassigned |
1
1
0 |
| 2.3.1.122 | Extensively Drug-Resistant Tuberculosis |
33333421 |
Identification of potent Antigen 85C inhibitors of Mycobacterium tuberculosis via in-house lichen library and binding free energy studies Part-II. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
| 2.3.1.122 | Fowlpox |
15196215 |
Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
